Payload Information
General Information of This Payload
| Payload ID | PAY0VOJYJ |
|||||
|---|---|---|---|---|---|---|
| Name | Cisplatin |
|||||
| Synonyms |
Cisplatin; 14913-33-8; trans-Dichlorodiamineplatinum(II); azane;dichloroplatinum; Platinum, diamminedichloro-, (SP-4-1)-; trans-Diamminedichloro platinum(II); trans-Platinum(II)diammine dichloride; MFCD00011623; trans-Dichlorodiamineplatinum(II);Transplatin; SR-05000001586; IA call; Trans-Platinum diammine dichloride; Cisplatin in water; Cisplatin,(S); Cisplatin in DMSO; DDP-H; PLATINOL (TN); Cl2-H6-N2-Pt; [Pt](Cl)(Cl)(N)N; SPECTRUM1502107; Cisplatin (JP17/USP/INN); cis-Diaminodichloroplatinum(II); HMS502M12; HMS1921J18; HMS2092D04; BCP01792; BCP18182; CCG-39901; AKOS005137969; NCGC00094962-01; NCGC00094962-02; NCGC00094962-03; FT-0777996; C06911; D00275; cis-Diammineplatinum(II) dichloride, crystalline; Q412415; SR-01000076254; SR-01000076254-1; SR-05000001586-1; SR-05000001586-3; Z3182781436; Cisplatin, European Pharmacopoeia (EP) Reference Standard; Cisplatin, United States Pharmacopeia (USP) Reference Standard; cis-Diamineplatinum(II) dichloride, >=99.9% trace metals basis; Cisplatin impurity A, European Pharmacopoeia (EP) Reference Standard; Transplatin, United States Pharmacopeia (USP) Reference Standard; Cisplatin, Pharmaceutical Secondary Standard; Certified Reference Material
Click to Show/Hide
|
|||||
| Target(s) | Human Deoxyribonucleic acid (hDNA) | |||||
| Structure |
|
|||||
| Formula | Cl2H6N2Pt |
|||||
| Isosmiles | N.N.Cl[Pt]Cl |
|||||
| PubChem CID | ||||||
| InChI |
InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2
|
|||||
| InChIKey |
LXZZYRPGZAFOLE-UHFFFAOYSA-L
|
|||||
| IUPAC Name |
azane;dichloroplatinum
|
|||||
| Pharmaceutical Properties | Molecule Weight |
300.05 |
Polar area |
2 |
||
Complexity |
2.8 |
xlogp Value |
. |
|||
Heavy Count |
5 |
Rot Bonds |
0 |
|||
Hbond acc |
2 |
Hbond Donor |
2 |
|||
The activity data of This Payload
Each Antibody-drug Conjugate Related to This Payload
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.